Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telotristat etiprate in ulcerative colitis
NCT01456052Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jan 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of telotristat ethyl in ulcerative colitis (UC), sponsored by Lexicon Pharmaceuticals, Inc. Started Jan 2012; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01456052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456052.